Penetration of blood-brain barrier by gamma-aminobutyric acid at sites of freezing

Metabolism and brain uptake of gamma-aminobutyric acid in galactosamine-induced hepatic encephalopathy in rats

Kinetic studies of [3H]gamma-aminobutyric acid ([3H]GABA) after an intravenous injection were performed in normal rats and in rats with severe degree of hepatic encephalopathy due to fulminant hepatic failure induced by galactosamine. Moreover, plasma and brain GABA levels, and GABA and glutamic acid decarboxylase activity were studied in some brain areas. After intravenous injection, [3H]GABA disappeared very rapidly in the blood of normal rats, with a prompt increase of 3H metabolites. In comatose rats, a delayed disappearance of [3H]GABA was parallelled by a lower amount of metabolites, indirectly indicating a peripheral decrease of GABA-transaminase activity. The amount of [3H]GABA in brain was lightly but constantly lower in comatose rats than in controls, indicating that the change in permeability of the blood-brain barrier in hepatic encephalopathy does not affect the [3H]GABA uptake of the brain. Furthermore, the assay of endogenous GABA in blood, whole brain, and brain areas did not show any significant difference in any of the two groups. The finding that glutamic acid decarboxylase activity in brain was reduced, together with the indirect evidence of a reduction in GABA-transaminase, may account for the steady state of GABA in hepatic encephalopathy. However, the reduction in glutamic acid decarboxylase activity is in favor of a functional derangement at the GABA-ergic nerve terminals in this pathological condition.

GABA transaminase inhibitors

In summary, several branched-chain fatty acids appeared to be competitive inhibitors of GABA-T and non-competitive inhibitors of SSADH. These compounds produce an increase in brain GABA level, and for two of these it was shown that the increase differs among various brain areas. An increase of GABA cannot be obtained by inhibition of SSADH. The increase in brain GABA seems to correlate with the anticonvulsant activity of branched-chain fatty acids.

Effect of magnesium on epileptic foci

Parenteral magnesium sulfate has been used to control acute convulsions of diverse etiologies and is currently a mainstay in controlling eclamptic convulsions. However, the site of this anticonvulsant action has remained controversial and not well studied in experimental epileptic models. Therefore we determined the effects of intravenously infused magnesium sulfate on the epileptic neural activity induced by topical application of penicillin G to motor cortex in anesthetized cats and dogs and in awake, undrugged primates. Magnesium sulfate was able to directly suppress neuronal burst firing and interictal EEG spike generation at serum levels below those producing paralysis. The degree of suppression corresponded to the serum magnesium concentration and was reversible. These results corroborate the clinical observations in patients that magnesium can produce an anticonvulsant effect apart from neuromuscular blockade and suggest it may have clinical applicability in treating a wider range of acute convulsions.

The effect of intravenously administered gamma-aminobutyric acid on afferent fiber polarization

(1) The effect of intravenously administered gamma-aminobutyric acid (GABA) on afferent fiber polarization in the feline spinal cord was ascertained from fluctuations induced in the DC level of dorsal root filaments. (2) A dose-related depolarization of the filament, with a concomitant reduction in the magnitude of the dorsal root potential, was observed after 50 and 100 mg/kg GABA. (3) GABA also depolarized filaments of preparations in which interneuronal activity was suppressed by pretreatment with tetrodotoxin. Since the magnitude of the depolarization induced in these preparations was equal to that observed in nonpretreated animals, it is likely that the depolarization in the latter preparations reflects a direct effect on afferent terminals or fibers rather than an action on interneurons. (4) GABA failed to depolarize filaments in animals pretreated with bicuculline. This suggests that intravenously administered GABA interacted with receptors that are identical with or similar to those involved in neurally evoked primary afferent depolarization (PAD). (5) The direct depolarization of afferent fibers by intravenous GABA and the blockade thereof by bicuculline are characteristics compatible with those of the endogenous axo-axonic transmitter operating in pathways mediating neurally evoked PAD. These data, therefore, support the involvement of GABA at this synapse in the mammalian spinal cord.